BOSTON, Sept. 13, 2017 -- Dr. Paul Barth, co-founder and CEO of Podium Data, creator of the Podium Data Marketplace™ will tag team with a Podium customer to outline how this pharmaceutical innovator implemented their RWE data lake in less than 6 months, reducing the time required to deliver new analytic insights to the business from 3 months, to just 2 days.
The session titled “Unlocking the Power of Real World Evidence Data” is taking place at noon on September 20th at the Hyatt Regency in Boston as part of the 5th annual Real-World Analytics Summit. To attend, register online here.
First, audience members will learn about the technology available to better harness real world evidence data by implementing an enterprise-scale data lake. Dr. Barth will address how to increase ROI from RWE data by empowering business teams to build their own unique data sets under a self-service on-demand model.
Additionally, the presenters will share how real-world evidence and technology has put them at the forefront of healthcare, turning innovative science into value for patients by implementing an enterprise-scale self-service RWE data lake.
About Podium Data
Podium Data is radically simplifying and accelerating the way companies manage, prepare and deliver business-ready data – the lifeblood of the modern enterprise. The Podium Data Marketplace is a turnkey big data management platform that goes beyond data lakes to give business analysts self-service, on-demand access to trusted data while ensuring quality and control. More information is available at www.podiumdata.com and follow us on Twitter at @PodiumData.
Media Contact
Glen Zimmerman [email protected]


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
First Western Ship Transits Strait of Hormuz Since Iran War Began
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 



